Magstim Receives the US FDA's Clearance of Transcranial Magnetic Stimulation for Obsessive Compulsive Disorder
Shots:
- The US FDA has cleared Horizon 3.0 (with/out StimGuide+) and E-z Cool Coil, the only navigated transcranial magnetic stimulation (TMS) system used to treat adult patients diagnosed with OCD as well as MDD. TMS technology helps to improve patient’s mental health and QoL
- The system combines and improves clinical workflows with treatment pulse quality scores to ensure patients’ precision treatment. Using targeted mapping and built-in protocols, the Magstim E-z Cool Coil can administer back-to-back treatments for MDD and OCD
- With the help of improved workflows and cutting-edge data analytics, clinical practices using Horizon 3.0 in the USA have improved patient care and tracked patient and clinical outcomes
Ref: Globenewswire | Image: Magstim
Related News:- Abbott’s Navitor Device Receives the US FDA’s Approval for the Treatment of Aortic Stenosis
Click here to read the full press release
Neha is a Senior Editor at PharmaShots. She is passionate and very enthusiastic about recent updates and developments in the life sciences and pharma industry. She covers Biopharma, MedTech, and Digital health segments along with different reports at PharmaShots. She can be contacted at connect@pharmashots.com.
